Skip to Main Content

Paper Details

Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma.
Blood Adv
8
2023
Author NameAffiliation
Andrew M EvensRutgers Cancer Institute of New Jersey
  • 1 - 1

Datasets

Release 1.2